Early 2026 has brought a series of consequential regulatory moves from the FDA, each reflecting a common thread: the agency ...
In this video interview, Mohammed Saeed, MD, PhD, chief medical officer of Solera Health, explores how AI models capable of ...
In today's ACT Brief, we explore how FDA clearance and reimbursement models support wearable adoption in clinical care, the importance of end-to-end data validation before patient enrollment, and FDA ...
Ultimately, the data and technology systems validation capability can become a strategic differentiator that enables faster ...
In this video interview, Mohammed Saeed, MD, PhD, chief medical officer of Solera Health, discusses how regulatory ...
In today's ACT Brief, we explore the data overload and alert fatigue challenges in integrating wearable data into clinical ...
Finally, we turn to how we do. Behavioral science provides powerful models for performance: motivation, ability, and ...
In this video interview, Mohammed Saeed, MD, PhD, chief medical officer of Solera Health, examines the operational challenges ...
In today's ACT Brief, we explore how continuous remote monitoring enables early clinical interventions, FDA guidance on ...
In this video interview, Mohammed Saeed, MD, PhD, chief medical officer of Solera Health, explains how continuous remote ...
The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results